Rosenson, Robert S.

Fenofibrate Therapy Ameliorates Fasting and Postprandial Lipoproteinemia, Oxidative Stress, and the Inflammatory Response in Subjects With Hypertriglyceridemia and the Metabolic Syndrome

Rosenson, R. S., Wolff, D. A., Huskin, A. L., Helenowski, I. B., & Rademaker, A. W. (2007) · Diabetes Care

Lipid metabolism and disordersLipoproteins and Cardiovascular Health

Cited by 117

Association of Serum Lipids and Coronary Heart Disease in Contemporary Observational Studies

Colantonio, L. D., Bittner, V., Reynolds, K., Levitan, E. B., Rosenson, R. S., Banach, M., Kent, S. T., Derose, S. F., Zhou, H., Safford, M. M., et al. (2016) · Circulation

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 105

PCSK9 Loss-of-Function Variants, Low-Density Lipoprotein Cholesterol, and Risk of Coronary Heart Disease and Stroke: Data From 9 Studies of Blacks and Whites

Kent, S. T., Rosenson, R. S., Avery, C. L., Chen, Y.-D. I., Correa, A., Cummings, S. R., Cupples, L. A., Cushman, M., Evans, D. S., Gudnason, V., et al. (2017) · Circulation: Cardiovascular Genetics

Lipoproteins and Cardiovascular HealthGenetic Associations and Epidemiology

Cited by 86

Efficacy and safety of evolocumab in individuals with type 2 diabetes mellitus: primary results of the randomised controlled BANTING study

Rosenson, R. S., Daviglus, M. L., Handelsman, Y., Pozzilli, P., Bays, H., Monsalvo, M. L., Elliott-Davey, M., Somaratne, R., & Reaven, P. (2019) · Diabetologia

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 73

Target Populations for Novel Triglyceride-Lowering Therapies

Nordestgaard, A. T., Tybjærg-Hansen, A., Mansbach, H., Kersten, S., Nordestgaard, B. G., & Rosenson, R. S. (2025) · Journal of the American College of Cardiology

Lipid metabolism and disordersLipoproteins and Cardiovascular Health

Cited by 54

PCSK9 Variants, Low-Density Lipoprotein Cholesterol, and Neurocognitive Impairment: Reasons for Geographic and Racial Differences in Stroke Study (REGARDS)

Mefford, M. T., Rosenson, R. S., Cushman, M., Farkouh, M. E., McClure, L. A., Wadley, V. G., Irvin, M. R., Bittner, V., Safford, M. M., Somaratne, R., et al. (2018) · Circulation

Lipoproteins and Cardiovascular HealthDementia and Cognitive Impairment Research

Cited by 44

Treating mixed hyperlipidemia and the atherogenic lipid phenotype for prevention of cardiovascular events

Rubenfire, M., Brook, R. D., & Rosenson, R. S. (2010) · The American Journal of Medicine

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 40

Efficacy and safety of the PCSK9 inhibitor evolocumab in patients with mixed hyperlipidemia

Rosenson, R. S., Jacobson, T. A., Preiss, D., Djedjos, C. S., Dent, R., Bridges, I., & Miller, M. (2016) · Cardiovascular Drugs and Therapy

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 36

Effects of evolocumab in individuals with type 2 diabetes with and without atherogenic dyslipidemia: an analysis from BANTING and BERSON

Lorenzatti, A. J., Monsalvo, M. L., López, J. A. G., Wang, H., & Rosenson, R. S. (2021) · Cardiovascular Diabetology

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 34

Fenofibrate reduces lipoprotein associated phospholipase A2 mass and oxidative lipids in hypertriglyceridemic subjects with the metabolic syndrome

Rosenson, R. S. (2008) · American Heart Journal

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 30

Metabolic dysfunction–associated steatotic liver disease, hypertriglyceridaemia, and cardiovascular risk

Gurevitz, C., & Rosenson, R. S. (2024) · European Journal of Preventive Cardiology

Liver Disease Diagnosis and TreatmentDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 19

Long-term levels of LDL-C and cognitive function: the CARDIA study

Mefford, M. T., Chen, L., Lewis, C. E., Muntner, P., Sidney, S., Launer, L. J., Monda, K. L., Ruzza, A., Kassahun, H., Rosenson, R. S., et al. (2021) · Journal of the International Neuropsychological Society

Lipoproteins and Cardiovascular HealthDementia and Cognitive Impairment Research

Cited by 15

Evinacumab Reduces Triglyceride-Rich Lipoproteins in Patients with Hyperlipidemia: A Post-Hoc Analysis of Three Randomized Clinical Trials

Rosenson, R. S., Rader, D. J., Ali, S., Banerjee, P., McGinniss, J., & Pordy, R. (2025) · Cardiovascular Drugs and Therapy

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 13

Efficacy of evinacumab in patients with severe hypertriglyceridemia and a history of severe hypertriglyceridemia-related acute pancreatitis: A phase 2b trial

Rosenson, R. S., George, R. T., Sanchez, R. J., Zhao, X.-Q., Ponda, M. P., Waldron, A., & Pordy, R. (2025) · Journal of Clinical Lipidology

Pancreatitis Pathology and TreatmentLipid metabolism and disorders

Cited by 11

Unmet Patient Need in Statin Intolerance: the Clinical Characteristics and Management

Harrison, T. N., Hsu, J.-W. Y., Rosenson, R. S., Levitan, E. B., Muntner, P., Cheetham, T. C., Wei, R., Scott, R. D., & Reynolds, K. (2018) · Cardiovascular Drugs and Therapy

Lipoproteins and Cardiovascular HealthCancer, Lipids, and Metabolism

Cited by 10

Abstract 17120: ARO-ANG3, an investigational RNAi therapeutic, silences the expression of ANGPTL3 and decreases atherogenic lipoproteins in patients with mixed dyslipidemia: ARCHES-2 study results

Watts, G. F., Gaudet, D., ALTAMIRANO, D., Hegele, R., Ballantyne, C. M., Nicholls, S., Chang, T., Alagarsamy, S., Fu, R., San Martin, J., et al. (2023) · Circulation

Lipid metabolism and disordersLipoproteins and Cardiovascular Health

Cited by 9

81Efficacy and safety of alternate-day versus daily dosing of statins: a systematic review and meta-analysis

Awad, K., Mikhailidis, D. P., Toth, P. P., Jones, S. R., Moriarty, P., Lip, G. Y. H., Muntner, P., Catapano, A. L., Pencina, M. J., Rosenson, R. S., et al. (2017) · European Heart Journal

Lipoproteins and Cardiovascular HealthAcute Myocardial Infarction Research

Cited by 2